Research Development Foundation

METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS

#2 | 2025-05-22

US20250161427A1

IMMUNOREACTIVE PEPTIDES

#3 | 2025-04-03

US20250107703A1

SYSTEMS AND METHODS FOR CORONARY OCCLUSION TREATMENT

#4 | 2024-12-26 ✅ Patent 12,226,468 granted on 2025-02-18

US20240424075A1

Immunoreactive peptides

#5 | 2024-10-03

US20240325461A1

COMBINATION THERAPIES FOR THE TREATMENT OF DISEASES

#6 | 2024-08-15

US20240270852A1

ENGINEERED ANTIBODY FC VARIANTS FOR ENHANCED SERUM HALF LIFE

#7 | 2024-08-15

US20240269303A1

CELL TARGETING CONSTRUCTS AND USES THEREOF

#8 | 2024-07-11

US20240229003A1

CELL-TARGETED CYTOTOXIC CONSTRUCTS

#9 | 2024-07-11

US20240225734A1

SYSTEMS AND METHODS FOR DIODE LASER-INDUCED CALCIUM FRACTURES

#10 | 2024-05-09

US20240148805A1

METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS

#11 | 2024-01-25

US20240023813A1

SYSTEMS AND METHODS FOR ULTRASOUND AND PHOTOACOUSTIC GUIDANCE OF CORONARY PROCEDURES

#12 | 2024-01-18 ✅ Patent 12,552,843 granted on 2026-02-17

US20240018195A1

CHIMERIC IMMUNOGENIC POLYPEPTIDES

#13 | 2024-01-11

US20240010742A1

ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF

#14 | 2023-12-07

US20230392115A1

METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS

#15 | 2023-10-12 ✅ Patent 12,013,342 granted on 2024-06-18

US20230324302A1

Apparatus and methods for endometrial tissue identification

#16 | 2023-10-12 ✅ Patent 12,171,408 granted on 2024-12-24

US20230320576A1

Systems and methods for coronary occlusion treatment

#17 | 2023-08-17

US20230257774A1

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#18 | 2023-08-17

US20230256038A1

METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS

#19 | 2023-07-06

US20230210973A1

PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION

#20 | 2023-06-29

US20230203467A1

SERINE PROTEASE MOLECULES AND THERAPIES

#21 | 2023-03-16 ✅ Patent 12,213,810 granted on 2025-02-04

US20230083484A1

Systems and methods for automated coronary plaque characterization and risk assessment using intravascular optical coherence tomography

#22 | 2022-12-01

US20220380832A1

METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE

#23 | 2022-11-10 ✅ Patent 12,624,093 granted on 2026-05-12

US20220356231A1

EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS

#24 | 2022-08-25

US20220267801A1

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#25 | 2022-08-25 ✅ Patent 11,913,043 granted on 2024-02-27

US20220267752A1

Cell-targeted cytotoxic constructs

#26 | 2022-07-07

US20220211436A1

METHODS AND APPARATUS FOR HIGH-SPEED AND HIGH-ASPECT RATIO LASER SUBTRACTIVE MATERIAL PROCESSING

#27 | 2022-06-16

US20220183756A1

SYSTEMS AND METHODS FOR LASER-INDUCED CALCIUM FRACTURES

#28 | 2022-05-12 ✅ Patent 12,458,807 granted on 2025-11-04

US20220143412A1

APPARATUS AND METHODS FOR PHASE-AGNOSTIC STIMULI

#29 | 2021-11-11 ✅ Patent 11,958,904 granted on 2024-04-16

US20210347891A1

Engineered antibody Fc variants for enhanced serum half life

#30 | 2021-10-28 ✅ Patent 12,404,332 granted on 2025-09-02

US20210332136A1

METHODS FOR DIAGNOSING AND TREATING CANCERS

#31 | 2021-09-30

US20210298603A1

SYSTEMS AND METHODS FOR IMAGING AND MANIPULATING TISSUE

#32 | 2021-09-23 ✅ Patent 11,780,892 granted on 2023-10-10

US20210292377A1

Chimeric immunogenic polypeptides

#33 | 2021-08-05 ✅ Patent 12,461,099 granted on 2025-11-04

US20210239695A1

IMMUNOREACTIVE POLYPEPTIDES

#34 | 2021-03-18 ✅ Patent 11,883,447 granted on 2024-01-30

US20210077549A1

Methods and probiotic compositions for the treatment of metabolic diseases and disorders

#35 | 2021-01-28

US20210024600A1

RECOMBINANT FILAGGRIN POLYPEPTIDES FOR CELL IMPORTATION

#36 | 2020-12-03 ✅ Patent 11,009,465 granted on 2021-05-18

US20200378896A1

Apparatus and methods for endometrial tissue identification

#37 | 2020-10-01 ✅ Patent 11,535,838 granted on 2022-12-27

US20200308565A1

Serine protease molecules and therapies

#38 | 2020-06-25 ✅ Patent 11,459,379 granted on 2022-10-04

US20200199205A1

Immunoreactive protein orthologs of and

#39 | 2020-06-18 ✅ Patent 11,779,220 granted on 2023-10-10

US20200187790A1

Multi-channel orthogonal convolutional neural networks

#40 | 2020-05-14 ✅ Patent 10,934,267 granted on 2021-03-02

US20200148661A1

Alpha-tea salt forms: compositions and uses for treating disease

#41 | 2020-04-02 ✅ Patent 11,332,538 granted on 2022-05-17

US20200102400A1

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

#42 | 2020-04-02 ✅ Patent 11,541,083 granted on 2023-01-03

US20200101121A1

Methods and probiotic compositions for the treatment of bone disorders

#43 | 2020-01-30 ✅ Patent 11,046,734 granted on 2021-06-29

US20200031877A1

Chimeric immunogenic polypeptides

#44 | 2020-01-09 ✅ Patent 10,920,211 granted on 2021-02-16

US20200010821A1

Serine protease molecules and therapies

#45 | 2019-11-21 ✅ Patent 11,168,327 granted on 2021-11-09

US20190352646A1

STEAP2 inhibitors for the treatment of liver cancers

#46 | 2019-08-22 ✅ Patent 10,738,295 granted on 2020-08-11

US20190256837A1

Serine protease molecules and therapies

#47 | 2019-08-01 ✅ Patent 11,426,422 granted on 2022-08-30

US20190231805A1

SHP2 inhibitors and methods of use thereof

#48 | 2019-05-30 ✅ Patent 11,236,380 granted on 2022-02-01

US20190161787A1

Methods for predicting kinase inhibitor resistance

#49 | 2019-05-30 ✅ Patent 11,542,524 granted on 2023-01-03

US20190160113A1

Elimination of proliferating cells from stem cell-derived grafts

#50 | 2019-05-02 ✅ Patent 11,098,097 granted on 2021-08-24

US20190127430A1

Recombinant filaggrin polypeptides for cell importation

#51 | 2019-02-14 ✅ Patent 11,059,892 granted on 2021-07-13

US20190048078A1

Engineered antibody Fc variants for enhanced serum half life

#52 | 2018-09-27

US20180271945A1

UROCORTIN 2 ANALOGS AND USES THEREOF

#53 | 2018-08-02

US20180214546A1

MODULATION OF SRPX2-MEDIATED ANGIOGENESIS

#54 | 2018-07-19 ✅ Patent 10,323,239 granted on 2019-06-18

US20180201918A1

Serine protease molecules and therapies

#55 | 2018-06-21 ✅ Patent 10,759,857 granted on 2020-09-01

US20180171013A1

JAM-C antibodies and methods for treatment of cancer

#56 | 2018-03-22 ✅ Patent 10,131,705 granted on 2018-11-20

US20180079803A1

Vaccines and diagnostics for the ehrlichioses

#57 | 2017-11-23 ✅ Patent 10,226,538 granted on 2019-03-12

US20170333573A1

Methods and compositions relating to improved lentiviral vectors and their applications

#58 | 2017-10-12 ✅ Patent 10,385,129 granted on 2019-08-20

US20170291944A1

JAM-C antibodies and methods for treatment of cancer

#59 | 2017-09-14 ✅ Patent 11,193,117 granted on 2021-12-07

US20170260517A1

Cell-targeted cytotoxic constructs

#60 | 2017-08-17 ✅ Patent 10,900,059 granted on 2021-01-26

US20170233781A1

Methods for generating engineered enzymes

#61 | 2017-08-17

US20170233444A1

RTEF-1 VARIANTS AND USES THEREOF

#62 | 2017-07-20

US20170204168A1

IMMUNOREACTIVE PROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSIS

#63 | 2017-07-06 ✅ Patent 10,258,639 granted on 2019-04-16

US20170189440A1

Methods for treating insulin resistance and for sensitizing patients to GLP1 agonist therapy

#64 | 2017-06-22 ✅ Patent 9,814,768 granted on 2017-11-14

US20170173136A1

Immunoreactive glycoprotein GP19 of

#65 | 2017-06-15 ✅ Patent 9,850,295 granted on 2017-12-26

US20170166628A1

Vaccines and diagnostics for the ehrlichioses

#66 | 2017-06-01

US20170151245A1

METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES AND AMYLOID BETA AMYLOIDOSIS BY MODULATING CRF RECEPTOR SIGNALING

#67 | 2017-05-04 ✅ Patent 10,495,440 granted on 2019-12-03

US20170122720A1

Apparatus and methods for optical coherence tomography and two-photon luminescence imaging

#68 | 2017-03-23 ✅ Patent 9,937,269 granted on 2018-04-10

US20170081377A1

RTEF-1 variants and the use thereof for inhibition of angiogenesis

#69 | 2017-03-09

US20170067079A1

METHODS AND COMPOSITIONS RELATING TO RESTRICTED EXPRESSION LENTIVIRAL VECTORS AND THEIR APPLICATIONS

#70 | 2017-03-02 ✅ Patent 10,526,408 granted on 2020-01-07

US20170058030A1

Engineered antibody FC variants

#71 | 2017-02-09

US20170037091A1

STY PEPTIDES FOR INHIBITION OF ANGIOGENESIS

#72 | 2016-12-29 ✅ Patent 9,731,033 granted on 2017-08-15

US20160375152A1

Methods and compositions relating to improved lentiviral vectors and their applications

#73 | 2016-12-29

US20160375102A1

UROCORTIN-III AND USES THEREOF

#74 | 2016-11-17

US20160333084A1

METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS

#75 | 2016-10-13 ✅ Patent 10,457,737 granted on 2019-10-29

US20160297886A1

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

#76 | 2016-08-25

US20160243142A1

AVICIN D FOR TREATMENT OF MANTLE CELL LYMPHOMA

#77 | 2016-07-28 ✅ Patent 10,370,350 granted on 2019-08-06

US20160214954A1

Alpha-TEA salt forms: compositions and uses for treating disease

#78 | 2016-03-24 ✅ Patent 9,645,148 granted on 2017-05-09

US20160084836A1

Immunoreactive protein orthologs of and

#79 | 2016-03-17 ✅ Patent 9,633,277 granted on 2017-04-25

US20160078309A1

Apparatus and methods for identifying and evaluating bright spot indications observed through optical coherence tomography

#80 | 2016-03-10 ✅ Patent 9,476,062 granted on 2016-10-25

US20160068862A1

Methods and compositions relating to improved lentiviral vectors and their applications

#81 | 2016-01-28

US20160022780A1

UROCORTIN 2 ANALOGS AND USES THEREOF

#82 | 2015-12-24 ✅ Patent 9,388,397 granted on 2016-07-12

US20150368628A1

Deimmunized gelonin molecules and therapies

#83 | 2015-11-26 ✅ Patent 9,605,033 granted on 2017-03-28

US20150338406A1

Immunoreactive glycoprotein GP19 of

#84 | 2015-11-26 ✅ Patent 9,605,036 granted on 2017-03-28

US20150338405A1

Vaccines and diagnostics for the

#85 | 2015-11-05 ✅ Patent 9,572,866 granted on 2017-02-21

US20150315257A1

Urocortin 2 analogs and uses thereof

#86 | 2015-10-22

US20150299306A1

METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS

#87 | 2015-10-15 ✅ Patent 9,693,994 granted on 2017-07-04

US20150290168A1

Class IIa HDAC inhibitors for the treatment of infection

#88 | 2015-09-03 ✅ Patent 9,803,014 granted on 2017-10-31

US20150246971A1

JAM-C antibodies and methods for treatment of cancer

#89 | 2015-07-23 ✅ Patent 9,260,725 granted on 2016-02-16

US20150203870A1

Methods and compositions relating to improved lentiviral vector production systems

#90 | 2015-07-23 ✅ Patent 9,546,359 granted on 2017-01-17

US20150203834A1

Method for engineering proteases and protein kinases

#91 | 2015-07-02 ✅ Patent 9,771,426 granted on 2017-09-26

US20150183873A1

Engineered immunoglobulin FC polypeptides

#92 | 2015-04-30 ✅ Patent 9,250,240 granted on 2016-02-02

US20150119276A1

Immunoreactive p120/p140 epitopes and uses thereof

#93 | 2015-04-09 ✅ Patent 10,808,026 granted on 2020-10-20

US20150098947A1

Monoclonal Olfml-3 antibodies and uses thereof

#94 | 2015-01-08 ✅ Patent 9,951,325 granted on 2018-04-24

US20150010556A1

Serine protease molecules and therapies

#95 | 2014-12-04 ✅ Patent 9,650,426 granted on 2017-05-16

US20140357704A1

RTEF-1 variants and uses thereof

#96 | 2014-11-13 ✅ Patent 9,340,798 granted on 2016-05-17

US20140335607A1

Methods and compositions relating to restricted expression lentiviral vectors and their applications

#97 | 2014-10-30 ✅ Patent 9,512,423 granted on 2016-12-06

US20140322205A1

RTEF-1 variants and the use thereof for inhibition of angiogenesis

#98 | 2014-10-23 ✅ Patent 9,499,807 granted on 2016-11-22

US20140314760A1

Serine protease molecules and therapies

#99 | 2014-09-25

US20140288418A1

APPARATUS AND METHODS FOR PATHLENGTH MULTIPLEXING FOR ANGLE RESOLVED OPTICAL COHERENCE TOMOGRAPHY

#100 | 2014-09-25 ✅ Patent 9,388,229 granted on 2016-07-12

US20140288161A1